Cargando…
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which reli...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820467/ https://www.ncbi.nlm.nih.gov/pubmed/33479235 http://dx.doi.org/10.1038/s41467-020-20819-4 |
_version_ | 1783639220160561152 |
---|---|
author | Lippert, Timothy P. Marzec, Paulina Idilli, Aurora I. Sarek, Grzegorz Vancevska, Aleksandra Bower, Mark Farrell, Paul J. Ojala, Päivi M. Feldhahn, Niklas Boulton, Simon J. |
author_facet | Lippert, Timothy P. Marzec, Paulina Idilli, Aurora I. Sarek, Grzegorz Vancevska, Aleksandra Bower, Mark Farrell, Paul J. Ojala, Päivi M. Feldhahn, Niklas Boulton, Simon J. |
author_sort | Lippert, Timothy P. |
collection | PubMed |
description | To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which relies on break-induced replication (BIR) and telomere recombination. Although ALT tumours were first reported over 20 years ago, the mechanism of ALT induction remains unclear and no study to date has described a cell-based model that permits the induction of ALT. Here, we demonstrate that infection with Kaposi’s sarcoma herpesvirus (KSHV) induces sustained acquisition of ALT-like features in previously non-ALT cell lines. KSHV-infected cells acquire hallmarks of ALT activity that are also observed in KSHV-associated tumour biopsies. Down-regulating BIR impairs KSHV latency, suggesting that KSHV co-opts ALT for viral functionality. This study uncovers KSHV infection as a means to study telomere maintenance by ALT and reveals features of ALT in KSHV-associated tumours. |
format | Online Article Text |
id | pubmed-7820467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78204672021-01-29 Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres Lippert, Timothy P. Marzec, Paulina Idilli, Aurora I. Sarek, Grzegorz Vancevska, Aleksandra Bower, Mark Farrell, Paul J. Ojala, Päivi M. Feldhahn, Niklas Boulton, Simon J. Nat Commun Article To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which relies on break-induced replication (BIR) and telomere recombination. Although ALT tumours were first reported over 20 years ago, the mechanism of ALT induction remains unclear and no study to date has described a cell-based model that permits the induction of ALT. Here, we demonstrate that infection with Kaposi’s sarcoma herpesvirus (KSHV) induces sustained acquisition of ALT-like features in previously non-ALT cell lines. KSHV-infected cells acquire hallmarks of ALT activity that are also observed in KSHV-associated tumour biopsies. Down-regulating BIR impairs KSHV latency, suggesting that KSHV co-opts ALT for viral functionality. This study uncovers KSHV infection as a means to study telomere maintenance by ALT and reveals features of ALT in KSHV-associated tumours. Nature Publishing Group UK 2021-01-21 /pmc/articles/PMC7820467/ /pubmed/33479235 http://dx.doi.org/10.1038/s41467-020-20819-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lippert, Timothy P. Marzec, Paulina Idilli, Aurora I. Sarek, Grzegorz Vancevska, Aleksandra Bower, Mark Farrell, Paul J. Ojala, Päivi M. Feldhahn, Niklas Boulton, Simon J. Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title | Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title_full | Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title_fullStr | Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title_full_unstemmed | Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title_short | Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres |
title_sort | oncogenic herpesvirus kshv triggers hallmarks of alternative lengthening of telomeres |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820467/ https://www.ncbi.nlm.nih.gov/pubmed/33479235 http://dx.doi.org/10.1038/s41467-020-20819-4 |
work_keys_str_mv | AT lipperttimothyp oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT marzecpaulina oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT idilliaurorai oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT sarekgrzegorz oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT vancevskaaleksandra oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT bowermark oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT farrellpaulj oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT ojalapaivim oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT feldhahnniklas oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres AT boultonsimonj oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres |